Scribd
Upload
208 views2 pages

Generic & Trade Name of Drug: Novolog Insulin, Novolog: Adult: SC 0.25-0.7 Units/kg/d Injected 5-10 Min Before Each Meal

Novolog insulin is a synthetic substitute hormone used to treat diabetes. It works faster than regular human insulin, lowering blood glucose levels within 15 minutes of subcutaneous injection and peaking within 40-50 minutes. The dosage is typically 0.25-0.7 units per kg of body weight daily, injected 5-10 minutes before meals. Side effects include hypoglycemia, hypokalemia, and injection site reactions. Patients should monitor their blood sugar levels regularly and treat hypoglycemia promptly.

Uploaded by

jshcfdhsgfveugwd8iu
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
208 views2 pages

Generic & Trade Name of Drug: Novolog Insulin, Novolog: Adult: SC 0.25-0.7 Units/kg/d Injected 5-10 Min Before Each Meal

Novolog insulin is a synthetic substitute hormone used to treat diabetes. It works faster than regular human insulin, lowering blood glucose levels within 15 minutes of subcutaneous injection and peaking within 40-50 minutes. The dosage is typically 0.25-0.7 units per kg of body weight daily, injected 5-10 minutes before meals. Side effects include hypoglycemia, hypokalemia, and injection site reactions. Patients should monitor their blood sugar levels regularly and treat hypoglycemia promptly.

Uploaded by

jshcfdhsgfveugwd8iu
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 2

Generic & Trade Name of Drug: Novolog 

Insulin, Novolog

CLASSIFICATION OF DRUG: HORMONE AND SYNTHETIC SUBSTITUTE; ANTIDIABETIC AGENT; INSULIN

Indications/
Therapeutic Effects:
Provides better blood glucose control than regular human insulin when given before a meal.
Diabetes
Dosage Range:
Adult: SC 0.25–0.7 units/kg/d injected 5–10 min before each meal
Subcutaneous
 Note: Must give 5–10 min before a meal. 
Routes of
Administration:  Draw up insulin aspart first when mixing with NPH insulin. Give injection immediately after it is mixed. Do not give NPH mixture by IV.
 Store refrigerated at 2°–8° C (36°–46° F); may be stored at room temperature, 15°–30° C (59°–86° F) for up to 28 d. Do not expose to
excessive heat or sunlight, and do not freeze.
Absorption: Rapidly absorbed from SC injection site. 
Onset: 15 min. 
Peak: 40–50 min. 
Pharmacokinetics: Duration: 3–5 h.
 Distribution: Low protein binding. 
Metabolism: Metabolized primarily in liver with some metabolism in the kidneys.
 Half-Life: 81 min.
Nursing Implications/  Monitor for S&S of hypoglycemia. Initial hypoglycemic response begins within 15 min and peaks 45–90 min after injection.
Assessments:  Lab tests: Periodically monitor fasting blood glucose and HbA1C.
 Withhold drug and notify physician if patient is hypokalemic.
Body as a Whole: Allergic reactions. 
Side/ Adverse Effects: Endocrine: Hypoglycemia, hypokalemia. 
Skin: Injection site reaction, lipodystrophy, pruritus, rash.
Contraindications: Systemic allergic reactions; history of allergic reactions to insulin; hypoglycemia; pregnancy (category C).
Client Teaching:  Do not inject into areas with redness, swelling, itching, or dimpling.
 Ingest some form of sugar (e.g., orange juice, dissolved table sugar, honey) if symptoms of hypoglycemia develop, and seek medical assistance.
 Check blood sugar as prescribed, especially postprandial values; notify physician of fasting blood glucose <80 and >120 mg/dL.
 Notify the physician of any of the following: Fever, infection, trauma, diarrhea, nausea or vomiting. Dosage adjustment may be needed.
 Do not take any other medication unless approved by the physician.
 Do not breast feed while taking this drug without consulting physician.

Other:

Inspiring Nursing as if EVERY Person matters…

You might also like